Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia
Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia have?
Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia has 29 citations in the OpenAlex counts ScholarIQ stores.
When was Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia published?
Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia has 2021 year in the ScholarIQ index.
What is the open-access status of Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia?
Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia has green oa status in the ScholarIQ index.
What is the DOI of Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia?
The DOI for Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia is on the source record.
What is the PMID of Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia?
The PMID for Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia is on the source record.
What is the OpenAlex record for Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia?
The OpenAlex for Discovery of a Potent and Selective FLT3 Inhibitor (<i>Z</i>)-<i>N</i>-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1<i>H</i>-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia is on the source record.